Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;13(7):542-52.
doi: 10.4161/cbt.19604. Epub 2012 May 1.

Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells

Affiliations

Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cells

Yan Shen et al. Cancer Biol Ther. 2012 May.

Abstract

Accumulating evidence suggests that chemopreventive effects of some dietary polyphenols may in part be mediated by their ability to influence epigenetic mechanisms in cancer cells. Boswellic acids, derived from the plant Boswellia serrata, have long been used for the treatment of various inflammatory diseases due to their potent anti-inflammatory activities. Recent preclinical studies have also suggested that this compound has anti-cancer potential against various malignancies. However, the precise molecular mechanisms underlying their anti-cancer effects remain elusive. Herein, we report that boswellic acids modulate DNA methylation status of several tumor suppressor genes in colorectal cancer (CRC) cells. We treated RKO, SW48 and SW480 CRC cell lines with the active principle present in boswellic acids, acetyl-keto-β-boswellic acid (AKBA). Using genome-wide DNA methylation and gene expression microarray analyses, we discovered that AKBA induced a modest genome-wide demethylation that permitted simultaneous re-activation of the corresponding tumor suppressor genes. The quantitative methylation-specific PCR and RT-PCR validated the gene demethylation and re-expression in several putative tumor suppressor genes including SAMD14 and SMPD3. Furthermore, AKBA inhibited DNMT activity in CRC cells. Taken together, these results lend further support to the growing notion that anti-cancer effect of boswellic acids may in part be due to its ability to demethylate and reactivate methylation-silenced tumor suppressor genes. These results suggest that not only boswellic acid might be a promising epigenetic modulator in the chemoprevention and treatment of CRC, but also provide a rationale for future investigations on the usefulness of such botanicals for epigenetic therapy in other human malignancies.

PubMed Disclaimer

Figures

None
Figure 1. AKBA exerts anticancer effects in CRC cell lines. (A) The molecular structure of AKBA. (B) AKBA treatment inhibits cell viability in RKO, SW48 and SW480 cells using a MTT assay. (C) AKBA reduces proliferation of CRC cells in a BrdU assay. AKBA induces apoptosis in RKO (D), SW48 (E) and SW480 (F) cells in an immunofluorescence staining assay that uses an anti-active caspase-3 antibody. Data are represented as mean ± standard error of mean (SEM) from three independent experiments.
None
Figure 2. AKBA demethylates CpG islands in CRC cells. (A) A scatter plot comparing the β-values of all CpG loci between control and DAC-treated (2.5 μM) SW48 CRC cells (top panel), and between control and AKBA (20 μM) treated cells (bottom panel). Colored dots represent β-value densities for each CpG locus. The histograms represent mean β-value distribution in SW48 cells treated with DAC (top panel) and those treated with AKBA for 6 d (bottom panel). The horizontal line within the box represents the median values. The upper and lower lines in the box plot represent 75th and 25th percentiles. The horizontal bars above and below the boxes represent the maximum and the minimum values. The small black box within each box plot represents median β-values. The differences in the mean β-values between the control, DAC and AKBA treated SW48 cells were analyzed by use of a two-tailed Student’s t-test. (B) A heat map illustration of the DNA methylation pattern of the control and AKBA treated cells (left panel). The gradient of blue to yellow represents individual β-values, and the degree of methylation from low (blue) to high (yellow; 0 to 1) as indicated. The three clusters of genes that demonstrated the most significant DNA demethylation after AKBA treatment are shown with red boxes. A close-up view of the heat maps corresponding to the subset of demethylated genes in the clusters 1, 2 and 3 are represented in the right panel. (C) The scatter plot of the β-values from the gene clusters 1, 2 and 3 (red, green and blue respectively) in AKBA vs control cells.
None
Figure 3. Correlation between DNA demethylation and re-expression of the corresponding genes in AKBA treated CRC cells. The scatter plot illustration of DNA methylation (β-values) data obtained from genome-wide methylation arrays and the changes in gene expression analyzed by microarray analyses in SW48 cells treated with AKBA. The methylation status after AKBA treatment is shown for each gene from clusters 1, 2 or 3 (colored red, green or blue, respectively, left panel). As shown in the right panel, the majority of demethylated genes within each of the three clusters were upregulated after AKBA treatment (76, 78, and 73% respectively).
None
Figure 4. The pathway analysis revealed the most affected molecular pathway by AKBA. (A) The pathway analysis revealed that CRC metastasis signaling was among one of the top five canonical pathways that served as a target of AKBA-induced demethylation in CRC cells. (B) An illustration from Ingenuity Pathway Analysis (IPA) demonstrating the biological relationship between demethylated and overexpressed genes from the 3 genes clusters. Green bolded BM represents the genes that are described as biomarkers of CRC, Orange Fx represents the genes that have direct function in CRC, and CP represents the canonical pathway involved in CRC metastasis signaling. One of the genes, SMPD3, which was found within the most demethylated gene group “cluster 1” in the methylation microarray analysis and subsequently confirmed in our validation analysis (expression by qRT-PCR and methylation by qMSP), is marked with “*” in red. Density of red color of icons and the number below the icons represents the fold change of gene expression induced by AKBA obtained in our genome-wide gene expression analysis.
None
Figure 5. Validation of DNA methylation and gene expression status of the selected putative tumor suppressor genes in three CRC cell lines. Re-expression and demethylation of nine putative tumor suppressor genes were confirmed by real-time RT-PCR and quantitative MSP in three CRC cell lines: SW48 (A), SW480 (B) and RKO (C) treated with 20 μM AKBA (SW48 and RKO) or 30 μM of AKBA (SW480) for 6 d. Six of the nine genes (CCNG2, FHIT, PTPRG, PRDM13, SAMD14 and TP53BP2) were upregulated along with demethylation in at least in two of the cell lines. Data are represented as mean ± SEM from two or three independent experiments.
None
Figure 6. AKBA inhibits DNMT activity in CRC cells. DNMT activity was measured in SW48 (A) and SW480 (B) cells treated with DMSO, 20 μM AKBA and 40 μM AKBA for three days. Data are represented as mean ± SEM from three independent experiments.

Similar articles

Cited by

References

    1. Shah BA, Qazi GN, Taneja SC. Boswellic acids: a group of medicinally important compounds. Nat Prod Rep. 2009;26:72–89. doi: 10.1039/b809437n. - DOI - PubMed
    1. Moussaieff A, Mechoulam R. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol. 2009;61:1281–93. - PubMed
    1. Gupta I, Parihar A, Malhotra P, Singh GB, Lüdtke R, Safayhi H, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997;2:37–43. - PubMed
    1. Sharma ML, Bani S, Singh GB. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol. 1989;11:647–52. doi: 10.1016/0192-0561(89)90150-1. - DOI - PubMed
    1. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. [Therapy of active Crohn disease with Boswellia serrata extract H 15] Z Gastroenterol. 2001;39:11–7. doi: 10.1055/s-2001-10708. - DOI - PubMed

Publication types

MeSH terms